Mathieu Streiff
About Mathieu Streiff
Mathieu B. Streiff (age 49) has served on American Healthcare REIT, Inc.’s (AHR) Board since October 2021; he is classified as a non‑independent director given his prior executive roles at AHR and affiliate ownership ties. He previously served as Chief Operating Officer (Oct 2021–Aug 2022), Executive Vice President (Aug 2022–Dec 2022), and Executive Vice President & General Counsel (Jan 2015–Oct 2021); he is also a founder/owner of AHI Group Holdings. He holds a B.S. in Environmental Economics & Policy from UC Berkeley and a J.D. from Columbia Law School .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| American Healthcare REIT, Inc. | Director | Oct 2021–present | Non‑independent director; no committee assignments disclosed for Streiff |
| American Healthcare REIT, Inc. | Chief Operating Officer | Oct 2021–Aug 2022 | Oversight of operations; legal/transactional background |
| American Healthcare REIT, Inc. | Executive Vice President | Aug 2022–Dec 2022 | Senior leadership capacity |
| American Healthcare REIT, Inc. | Executive Vice President & General Counsel | Jan 2015–Oct 2021 | Corporate finance, acquisitions/financings, asset management |
| GAHR II / GAHR III | Executive Vice President / General Counsel | 2012–2014 (GAHR II); 2013–2021 (GAHR III) | Transaction structuring and governance roles |
| AHI (American Healthcare Investors) | Founding principal; Managing Director; General Counsel | Dec 2014–Oct 2021 (MD); Dec 2014–Dec 2019 (GC) | Founding leadership; investment platform management |
| Grubb & Ellis | General Counsel; EVP; Secretary | Oct 2010–Jun 2011 (GC/EVP/Secretary); various roles 2006–2011 | Corporate legal leadership |
| Latham & Watkins LLP (NY) | Associate (Real Estate Dept.) | Sep 2002–Mar 2006 | Real estate transactional law |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Trilogy (operator affiliate) | Director | Dec 2015–Nov 2022 | Board member during AHR’s majority ownership period of Trilogy REIT Holdings |
Board Governance
- Independence: Streiff is designated not independent by the Board under NYSE rules (majority of AHR’s Board is independent; Streiff, Hanson, Prosky are not) .
- Committees: Current standing committees (Audit, Compensation, Nominating & Corporate Governance) are composed solely of independent directors; Streiff has no committee role listed in the proxy .
- Attendance: The Board held nine meetings in 2024; each incumbent director attended at least 75% of Board and applicable committee meetings; all directors attended the most recent annual meeting .
- Board leadership: Non‑executive Chair (Jeffrey T. Hanson); no Lead Independent Director; independent directors hold executive sessions at least annually .
- 2025 election outcome for Streiff: 111,148,837 For; 6,123,689 Withheld; 22,564,319 Broker Non‑Votes .
Fixed Compensation
| Year | Cash Retainer ($) | Committee Fees ($) | Other Cash ($) | Notes |
|---|---|---|---|---|
| 2024 | 85,000 | — (no committee role disclosed for Streiff) | 8,580 (distributions linked to director stock awards) | Independent directors’ fee schedule disclosed; Streiff listed as non‑independent |
Performance Compensation
| Award Type | Grant/Plan Details | Shares/Value | Vesting | Notes |
|---|---|---|---|---|
| Restricted Stock (Listing Equity Awards) | Non‑employee director award in connection with Feb 2024 listing | 7,407 shares to each non‑employee director (excl. Prosky) | 25% annually on each of the first four anniversaries of Feb 9, 2024, subject to continuous service | Time‑based; no performance metrics disclosed for director grants |
| 2024 Stock Awards (fair value) | Grant‑date fair value per ASC 718 | $192,159 | As per RSA schedule above | Reflects 2024 director equity grant |
| Nonvested RS balance (12/31/2024) | Aggregate restricted common shares held | 11,017 shares | As scheduled | Directors are reimbursed for meeting expenses; no options disclosed for directors |
Other Directorships & Interlocks
| Counterparty | Relationship | Potential Interlock/Conflict Vector | Details |
|---|---|---|---|
| AHI Group Holdings, LLC | AHR OP Unit limited partner; owned/controlled by Hanson, Prosky, Streiff | Affiliate and related‑party exposure; capital/ownership alignment with management | AHI holds OP Units; its principals (including Streiff) can influence affiliate holdings; OP Unit redemption features shifted classification post‑listing |
| Trilogy REIT Holdings / Trilogy Investors, LLC | Former minority JV partner bought out; AHR now 100% owner | Historical board overlap (Streiff on Trilogy board through Nov 2022) | AHR purchased NHI’s 24% interest for $258,001,000 (Sep 20, 2024), consolidating Trilogy |
Expertise & Qualifications
- Legal and transactional expertise: Former GC and senior legal roles at AHR, GAHR II/III, Grubb & Ellis; Latham & Watkins real estate associate; deep experience in acquisitions, financings, dispositions, and corporate finance .
- Operational leadership: Served as COO and EVP at AHR during key integration and listing period, bringing operational credibility to the Board .
- Education: B.S. Environmental Economics & Policy (UC Berkeley); J.D. (Columbia Law School) .
Equity Ownership
| Holder | Common Shares | OP Units | % of Common | Notes |
|---|---|---|---|---|
| Mathieu B. Streiff | 186,737 | 1,268,643 | <1.0% (asterisk category) | Beneficial ownership as of Mar 27, 2025; excludes OP Units held by third parties |
| Nonvested restricted shares (director) | 11,017 | — | — | Aggregate nonvested RS as of Dec 31, 2024 |
Governance Assessment
-
Independence risk: Streiff is a non‑independent director with prior executive service and co‑ownership of AHI Group Holdings (an OP Unit holder), creating potential conflicts or perceived management alignment; this can temper investor confidence around fully independent oversight .
-
Committee insulation: Audit, Compensation, and Nominating & Corporate Governance committees are fully independent, and Streiff does not sit on these committees—this mitigates conflict risk in key oversight areas .
-
Attendance and engagement: Board met nine times in 2024; all incumbent directors met the 75% attendance threshold and attended the annual meeting, indicating baseline engagement .
-
Shareholder signals: 2025 annual meeting support for Streiff’s election (111.1M For vs. 6.1M Withheld) suggests general shareholder acceptance; say‑on‑pay passed (109.3M For; 7.5M Against; 450K Abstain; broker non‑votes 22.6M), indicating no compensation backlash in 2024 .
-
Equity alignment: Director equity awards are time‑based RSAs with four‑year vesting; no performance metrics disclosed for directors. Streiff’s common shares plus material OP Unit interest reflect skin‑in‑the‑game, but affiliate OP Units via AHI Group Holdings introduce related‑party considerations .
-
RED FLAGS
- Non‑independence with prior executive tenure and affiliate ownership (AHI Group Holdings OP Units) .
- No Lead Independent Director at the board level (though committees are fully independent) .
- Related‑party/affiliate dynamics require vigilant conflict resolution via Nominating & Corporate Governance Committee processes .
-
Mitigants
- Fully independent key committees and explicit conflict‑resolution oversight mandate in Nominating & Corporate Governance Committee charter .
- Formal recoupment/clawback policy authorization under Compensation Committee charter, enhancing pay discipline .
Overall, Streiff brings legal and operational depth but remains a governance sensitivity point due to non‑independence and affiliate OP Unit interests; continued strict committee‑level independence and conflict management will be important for investor confidence .